Kelsey Goodwin
Stock Analyst at Piper Sandler
(4.89)
# 285
Out of 5,096 analysts
97
Total ratings
64.4%
Success rate
50.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelsey Goodwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNGX Tango Therapeutics | Reiterated: Hold | $24 | $22.72 | +5.63% | 5 | Oct 1, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Hold | $16 | $16.03 | -0.19% | 7 | Sep 29, 2026 | |
| LONA LeonaBio | Reiterated: Buy | $20 | $4.94 | +304.86% | 4 | Sep 21, 2026 | |
| OLMA Olema Pharmaceuticals | Reiterated: Buy | $40 | $7.00 | +471.43% | 5 | Aug 20, 2026 | |
| ERAS Erasca | Reiterated: Buy | $18 → $22 | $14.35 | +53.31% | 6 | Aug 12, 2026 | |
| CGON CG Oncology | Reiterated: Buy | $82 → $85 | $64.68 | +31.42% | 9 | Aug 7, 2026 | |
| JANX Janux Therapeutics | Reiterated: Buy | $26 | $17.47 | +48.83% | 8 | Aug 7, 2026 | |
| RLMD Relmada Therapeutics | Reiterated: Buy | $12 | $3.58 | +235.20% | 3 | Aug 7, 2026 | |
| BDTX Black Diamond Therapeutics | Reiterated: Buy | $8 | $1.78 | +349.44% | 5 | Aug 6, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $172 → $210 | $191.31 | +9.77% | 9 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $42 | $14.79 | +183.98% | 1 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $22 | $9.24 | +138.10% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $2.48 | +867.74% | 7 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $32.72 | +22.25% | 8 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.53 | - | 1 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $9.13 | +294.30% | 2 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.47 | n/a | 3 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.08 | n/a | 3 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.48 | n/a | 2 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.40 | n/a | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $21.63 | n/a | 1 | Oct 31, 2022 |
Tango Therapeutics
Oct 1, 2026
Reiterated: Hold
Price Target: $24
Current: $22.72
Upside: +5.63%
Summit Therapeutics
Sep 29, 2026
Reiterated: Hold
Price Target: $16
Current: $16.03
Upside: -0.19%
LeonaBio
Sep 21, 2026
Reiterated: Buy
Price Target: $20
Current: $4.94
Upside: +304.86%
Olema Pharmaceuticals
Aug 20, 2026
Reiterated: Buy
Price Target: $40
Current: $7.00
Upside: +471.43%
Erasca
Aug 12, 2026
Reiterated: Buy
Price Target: $18 → $22
Current: $14.35
Upside: +53.31%
CG Oncology
Aug 7, 2026
Reiterated: Buy
Price Target: $82 → $85
Current: $64.68
Upside: +31.42%
Janux Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $26
Current: $17.47
Upside: +48.83%
Relmada Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $12
Current: $3.58
Upside: +235.20%
Black Diamond Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $8
Current: $1.78
Upside: +349.44%
Revolution Medicines
Aug 6, 2026
Reiterated: Buy
Price Target: $172 → $210
Current: $191.31
Upside: +9.77%
Aug 4, 2026
Initiated Coverage: Buy
Price Target: $42
Current: $14.79
Upside: +183.98%
Aug 4, 2026
Rated: Buy
Price Target: $22
Current: $9.24
Upside: +138.10%
May 20, 2026
Reiterated: Buy
Price Target: $24
Current: $2.48
Upside: +867.74%
Apr 20, 2026
Reiterated: Buy
Price Target: $40
Current: $32.72
Upside: +22.25%
Mar 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.53
Upside: -
Dec 8, 2025
Reiterated: Buy
Price Target: $36
Current: $9.13
Upside: +294.30%
May 15, 2025
Reiterated: Buy
Price Target: $5
Current: $1.47
Upside: n/a
May 7, 2025
Reiterated: Buy
Price Target: $8
Current: $2.08
Upside: n/a
Apr 1, 2025
Reiterated: Hold
Price Target: n/a
Current: $8.48
Upside: n/a
Jul 30, 2024
Downgraded: Hold
Price Target: n/a
Current: $2.40
Upside: n/a
Oct 31, 2022
Initiated Coverage: Hold
Price Target: n/a
Current: $21.63
Upside: n/a